| Business Summary | | THERMOGENESIS
Corp.
designs,
manufactures
and
distributes
equipment
to
process
therapeutically
valuable
blood
components
including
stem
cells
and
surgical
sealants.
Initially,
the
Company
developed
medical
devices
for
ultra-rapid
freezing
and
thawing
of
blood
components,
which
the
Company
manufactures
and
distributes
in
the
niche
markets
in
the
blood
banks
of
32
countries.
The
Company's
Ultra
Rapid
freezers
and
thawers
use
heat
transfer
liquids,
rather
than
gases
such
as
air,
carbon
dioxide
or
nitrogen,
to
transfer
heat
to
and
from
a
biological
substance.
The
Company's
patented
thin
flexible
plastic
membrane
system
is
automatically
interposed
between
the
heat
transfer
liquid
and
the
container
housing
the
blood
component.
THERMOGENESIS
has
four
models
of
freezers
and
three
models
of
thawers. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | KOOL
designs,
develops,
manufactures
and
sells
devices
and
products
that
utilize
its
proprietary
thermodynamic
technology
for
the
processing
of
biological
substances.
For
the
nine
months
ended
3/31/01,
revenues
rose
40%
to
$4.6
million.
Net
loss
applicable
to
Common
and
before
accounting
change
fell
20%
to
$3.9
million.
Revenues
reflect
increased
sales
of
BioArchive
and
ThermoLine
products.
Lower
loss
reflects
cost
reduction
efforts. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Philip Coelho, 56 Chairman
and CEO | $187K | -- | James Godsey, Ph.D., 49 Pres,
COO | 170K | $63K | Renee Ruecker, 36 VP
- Fin./Accounting | -- | -- | Sam Acosta, 57 VP-
Manufacturing Operations | 138K | -- | David Adams, 42 Sec.,
Gen. Counsel | 111K | 152K | Dollar
amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|